首页> 外国专利> Anti-adrenomedullin (ADM) antibody or anti-ADM antibody fragment or anti-ADM non-Ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic or acute disease or acute condition

Anti-adrenomedullin (ADM) antibody or anti-ADM antibody fragment or anti-ADM non-Ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic or acute disease or acute condition

机译:抗肾上腺髓质素(ADM)抗体或抗ADM抗体片段或抗ADM非Ig支架,用于预防或减少患有慢性或急性疾病或急性疾病的患者的器官功能障碍或器官衰竭

摘要

Subject matter of the present disclosure is an anti-adrenomedullin (ADM) antibody or an anti-adrenomedullin antibody fragment or an anti-ADM non-lg scaffold for use in therapy of a chronical or acute disease or acute condition of a patient for prevention or reduction of organ dysfunction or organ failure. In a preferred embodiment subject matter of the disclosure is an anti-ADM antibody or an anti-adrenomedullin antibody fragment or anti-ADM non-lg scaffold for use in therapy of a chronical or acute disease or acute condition of a patient for prevention or reduction of kidney dysfunction or kidney failure or liver dysfunction or liver failure.
机译:本公开的主题是用于治疗或预防患者的慢性或急性疾病或急性病的抗肾上腺髓质素(ADM)抗体或抗肾上腺髓质素抗体片段或抗ADM非Ig支架。减少器官功能障碍或器官衰竭。在一个优选的实施方案中,本公开的主题是抗ADM抗体或抗肾上腺髓质素抗体片段或抗ADM非Ig支架,其用于治疗患者的慢性或急性疾病或急性病症以预防或减少。肾功能不全或肾衰竭或肝功能不全或肝衰竭。

著录项

  • 公开/公告号AU2012338731A1

    专利类型

  • 公开/公告日2014-05-29

    原文格式PDF

  • 申请/专利权人 ADRENOMED AG;

    申请/专利号AU2012338731A1

  • 发明设计人 BERGMANN ANDREAS;

    申请日2012-11-16

  • 分类号C07K16/26;A61K39/395;A61P9;A61P13/12;A61P31;

  • 国家 AU

  • 入库时间 2022-08-21 15:52:55

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号